In patients who have locally advanced and inoperable head and neck cancer, the
achievement of initial local control (complete response) of the disease with initial definitive …

Three hundred and thirteen patients with squamous cell cancer of the head and neck were
entered in a randomised clinical trial to determine whether the addition of methotrexate …

Head and neck cancers account| br about 5% of all cases with malignant neoplasia in the
US However, they remain an important cause of morbidity and mortality among cancer …

Perineural spread of tumour has been demonstrated in 24% of an unselected series of 70
patients with squamous carcinomas of the head and neck treated by surgery. Slightly more …

A rare cose of an 8½ year old boy with a stage III well differentiated squamous cell
carcinoma of the larynx, which responded to chemotherapy and irradiation, is reported. It is …

Anergy to 2, 4-dinitrochlorobenzene (DNCB) has been reported as a highly significant
adverse prognostic immunological factor in several studies of patients with squamous cell …

One hundred consecutive patients with previously untreated advanced squamous cell
carcinoma of the head and neck were treated with induction combination chemotherapy …

Patients presenting with Stage III‐IV squamous carcinoma of the head and neck often
relapse following aggressive surgery and/or radiotherapy. In an attempt to increase survival …

The 4‐year results of treatment of advanced squamous cell cancer of the head and neck
regions by radiotherapy combined with a cytotoxic regimen VBM (Vincristine, Bleomycin …

A low dose combination chemotherapy with VCR, BLM and MTX (VBM) in a theoretically
double synchronizing sequence was administered for palliative purpose to 84 patients with …